Andra AP fonden Has $17.72 Million Stock Position in Amgen Inc. $AMGN
MarketBeat
Last updated: July 21, 2026
Andra AP fonden has reduced its investment in Amgen Inc. (AMGN) by 18.9% in the first quarter, now holding approximately $17.72 million worth of Amgen stock. This adjustment signifies a strategic shift in the fund's portfolio allocation concerning the biotechnology company.
- Andra AP fonden's disclosure to the Securities & Exchange Commission reveals a decrease in its share ownership of Amgen Inc. The institutional investor previously held a certain number of shares and has since sold off a portion, resulting in a reduced position.
- Specifically, the fund's holdings were reduced by 18.9% during the first quarter of the year.
- Following this reduction, Andra AP fonden now owns 50,366 shares of Amgen Inc.
- The total value of this remaining stock position is estimated at $17.72 million.
- Amgen Inc. is identified as a medical research company.
- The reduction in holdings indicates a decrease in the fund's exposure to the biotechnology sector through this specific investment.
- This action reflects a typical portfolio management strategy by institutional investors to rebalance their investments based on market conditions or internal investment criteria.
- The transaction was reported in the fund's most recent filing with regulatory authorities.
